1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome

3. Executive Summary

3.1. Introduction
3.2. Market Outlook
3.3. End-User Outlook
3.4. Application Outlook
3.5. Geography Outlook
3.6. Competitor Outlook

4. Market Overview

4.1. Introduction

5. Market Dynamics

5.1. Introduction
5.2. Drivers
5.3. Restraints
5.4. Opportunities
5.5. Challenges

6. Market Insights

6.1. Porters Five Forces Analysis
6.1.1. Threat of New Entrants
6.1.2. Threat of Substitutes
6.1.3. Bargaining Power of Customers
6.1.4. Bargaining Power of Suppliers
6.1.5. Industry Rivalry
6.2. Cumulative Impact of COVID-19
6.3. Client Customizations

7. Global Oncology Biosimilars Market, By Application

7.1. Introduction
7.2. Cancer Treatment Drugs
7.3. Supportive Care Drugs

8. Global Oncology Biosimilars Market, By End-User

8.1. Introduction
8.2. Hospitals
8.3. Retail Pharmacies

9. Americas Oncology Biosimilars Market

9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Oncology Biosimilars Market

10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. South Korea
10.10. Thailand

11. Europe, Middle East & Africa Oncology Biosimilars Market

11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom

12. Competitive Landscape

12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion

13. Company Usability Profiles

13.1. Amgen
13.2. Baxter
13.3. Biocon
13.4. Cipla
13.5. Dr Reddy’s Laboratories
13.6. F Hoffmann-la Roche
13.7. Hospira
13.8. Pfizer
13.9. Sandoz
13.10. Sanofi

14. Appendix

14.1. Discussion Guide

List of Figures

FIGURE 1. GLOBAL ONCOLOGY BIOSIMILARS MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL ONCOLOGY BIOSIMILARS MARKET: RESEARCH EXECUTION
FIGURE 3. GLOBAL ONCOLOGY BIOSIMILARS MARKET SIZE, 2019 VS 2025 (USD MILLION)
FIGURE 4. GLOBAL ONCOLOGY BIOSIMILARS MARKET SIZE, BY END-USER, 2019 VS 2025 (USD MILLION)
FIGURE 5. GLOBAL ONCOLOGY BIOSIMILARS MARKET SIZE, BY APPLICATION, 2019 VS 2025 (USD MILLION)
FIGURE 6. GLOBAL ONCOLOGY BIOSIMILARS MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (USD MILLION)
FIGURE 7. GLOBAL ONCOLOGY BIOSIMILARS MARKET SIZE, 2017-2025 (USD MILLION)
FIGURE 8. GLOBAL ONCOLOGY BIOSIMILARS MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (%)
FIGURE 9. GLOBAL ONCOLOGY BIOSIMILARS MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (USD MILLION)
FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ONCOLOGY BIOSIMILARS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 11. GLOBAL ONCOLOGY BIOSIMILARS MARKET: MARKET DYNAMICS
FIGURE 12. GLOBAL ONCOLOGY BIOSIMILARS MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 13. GLOBAL ONCOLOGY BIOSIMILARS MARKET SIZE, BY APPLICATION, 2019 VS 2025 (%)
FIGURE 14. GLOBAL ONCOLOGY BIOSIMILARS MARKET SIZE, BY APPLICATION, 2019 VS 2025 (USD MILLION)
FIGURE 15. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ONCOLOGY BIOSIMILARS MARKET SIZE, BY APPLICATION, 2025
FIGURE 16. GLOBAL ONCOLOGY BIOSIMILARS MARKET SIZE, BY CANCER TREATMENT DRUGS, 2019 VS 2025 (USD MILLION)
FIGURE 17. GLOBAL ONCOLOGY BIOSIMILARS MARKET SIZE, BY SUPPORTIVE CARE DRUGS, 2019 VS 2025 (USD MILLION)
FIGURE 18. GLOBAL ONCOLOGY BIOSIMILARS MARKET SIZE, BY END-USER, 2019 VS 2025 (%)
FIGURE 19. GLOBAL ONCOLOGY BIOSIMILARS MARKET SIZE, BY END-USER, 2019 VS 2025 (USD MILLION)
FIGURE 20. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ONCOLOGY BIOSIMILARS MARKET SIZE, BY END-USER, 2025
FIGURE 21. GLOBAL ONCOLOGY BIOSIMILARS MARKET SIZE, BY HOSPITALS, 2019 VS 2025 (USD MILLION)
FIGURE 22. GLOBAL ONCOLOGY BIOSIMILARS MARKET SIZE, BY RETAIL PHARMACIES, 2019 VS 2025 (USD MILLION)
FIGURE 23. AMERICAS ONCOLOGY BIOSIMILARS MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (%)
FIGURE 24. AMERICAS ONCOLOGY BIOSIMILARS MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (USD MILLION)
FIGURE 25. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS ONCOLOGY BIOSIMILARS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 26. ARGENTINA ONCOLOGY BIOSIMILARS MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 27. BRAZIL ONCOLOGY BIOSIMILARS MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 28. CANADA ONCOLOGY BIOSIMILARS MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 29. MEXICO ONCOLOGY BIOSIMILARS MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 30. UNITED STATES ONCOLOGY BIOSIMILARS MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 31. ASIA-PACIFIC ONCOLOGY BIOSIMILARS MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (%)
FIGURE 32. ASIA-PACIFIC ONCOLOGY BIOSIMILARS MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (USD MILLION)
FIGURE 33. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC ONCOLOGY BIOSIMILARS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 34. AUSTRALIA ONCOLOGY BIOSIMILARS MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 35. CHINA ONCOLOGY BIOSIMILARS MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 36. INDIA ONCOLOGY BIOSIMILARS MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 37. INDONESIA ONCOLOGY BIOSIMILARS MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 38. JAPAN ONCOLOGY BIOSIMILARS MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 39. MALAYSIA ONCOLOGY BIOSIMILARS MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 40. PHILIPPINES ONCOLOGY BIOSIMILARS MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 41. SOUTH KOREA ONCOLOGY BIOSIMILARS MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 42. THAILAND ONCOLOGY BIOSIMILARS MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 43. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY BIOSIMILARS MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (%)
FIGURE 44. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY BIOSIMILARS MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (USD MILLION)
FIGURE 45. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA ONCOLOGY BIOSIMILARS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 46. FRANCE ONCOLOGY BIOSIMILARS MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 47. GERMANY ONCOLOGY BIOSIMILARS MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 48. ITALY ONCOLOGY BIOSIMILARS MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 49. NETHERLANDS ONCOLOGY BIOSIMILARS MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 50. QATAR ONCOLOGY BIOSIMILARS MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 51. RUSSIA ONCOLOGY BIOSIMILARS MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 52. SAUDI ARABIA ONCOLOGY BIOSIMILARS MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 53. SOUTH AFRICA ONCOLOGY BIOSIMILARS MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 54. SPAIN ONCOLOGY BIOSIMILARS MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 55. UNITED ARAB EMIRATES ONCOLOGY BIOSIMILARS MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 56. UNITED KINGDOM ONCOLOGY BIOSIMILARS MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 57. GLOBAL ONCOLOGY BIOSIMILARS MARKET: 360IRESEARCH FPNV POSITIONING MATRIX
FIGURE 58. GLOBAL ONCOLOGY BIOSIMILARS MARKET: 360IRESEARCH MARKET SHARE ANALYSIS
FIGURE 59. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL ONCOLOGY BIOSIMILARS MARKET, BY TYPE

List of Tables

TABLE 1. GLOBAL ONCOLOGY BIOSIMILARS MARKET SIZE, 2017-2025 (USD MILLION)
TABLE 2. GLOBAL ONCOLOGY BIOSIMILARS MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 3. GLOBAL ONCOLOGY BIOSIMILARS MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
TABLE 4. GLOBAL ONCOLOGY BIOSIMILARS MARKET SIZE, BY CANCER TREATMENT DRUGS, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 5. GLOBAL ONCOLOGY BIOSIMILARS MARKET SIZE, BY SUPPORTIVE CARE DRUGS, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 6. GLOBAL ONCOLOGY BIOSIMILARS MARKET SIZE, BY END-USER, 2017-2025 (USD MILLION)
TABLE 7. GLOBAL ONCOLOGY BIOSIMILARS MARKET SIZE, BY HOSPITALS, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 8. GLOBAL ONCOLOGY BIOSIMILARS MARKET SIZE, BY RETAIL PHARMACIES, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 9. AMERICAS ONCOLOGY BIOSIMILARS MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 10. AMERICAS ONCOLOGY BIOSIMILARS MARKET SIZE, BY END-USER, 2017-2025 (USD MILLION)
TABLE 11. AMERICAS ONCOLOGY BIOSIMILARS MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
TABLE 12. ARGENTINA ONCOLOGY BIOSIMILARS MARKET SIZE, BY END-USER, 2017-2025 (USD MILLION)
TABLE 13. ARGENTINA ONCOLOGY BIOSIMILARS MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
TABLE 14. BRAZIL ONCOLOGY BIOSIMILARS MARKET SIZE, BY END-USER, 2017-2025 (USD MILLION)
TABLE 15. BRAZIL ONCOLOGY BIOSIMILARS MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
TABLE 16. CANADA ONCOLOGY BIOSIMILARS MARKET SIZE, BY END-USER, 2017-2025 (USD MILLION)
TABLE 17. CANADA ONCOLOGY BIOSIMILARS MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
TABLE 18. MEXICO ONCOLOGY BIOSIMILARS MARKET SIZE, BY END-USER, 2017-2025 (USD MILLION)
TABLE 19. MEXICO ONCOLOGY BIOSIMILARS MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
TABLE 20. UNITED STATES ONCOLOGY BIOSIMILARS MARKET SIZE, BY END-USER, 2017-2025 (USD MILLION)
TABLE 21. UNITED STATES ONCOLOGY BIOSIMILARS MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
TABLE 22. ASIA-PACIFIC ONCOLOGY BIOSIMILARS MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 23. ASIA-PACIFIC ONCOLOGY BIOSIMILARS MARKET SIZE, BY END-USER, 2017-2025 (USD MILLION)
TABLE 24. ASIA-PACIFIC ONCOLOGY BIOSIMILARS MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
TABLE 25. AUSTRALIA ONCOLOGY BIOSIMILARS MARKET SIZE, BY END-USER, 2017-2025 (USD MILLION)
TABLE 26. AUSTRALIA ONCOLOGY BIOSIMILARS MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
TABLE 27. CHINA ONCOLOGY BIOSIMILARS MARKET SIZE, BY END-USER, 2017-2025 (USD MILLION)
TABLE 28. CHINA ONCOLOGY BIOSIMILARS MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
TABLE 29. INDIA ONCOLOGY BIOSIMILARS MARKET SIZE, BY END-USER, 2017-2025 (USD MILLION)
TABLE 30. INDIA ONCOLOGY BIOSIMILARS MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
TABLE 31. INDONESIA ONCOLOGY BIOSIMILARS MARKET SIZE, BY END-USER, 2017-2025 (USD MILLION)
TABLE 32. INDONESIA ONCOLOGY BIOSIMILARS MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
TABLE 33. JAPAN ONCOLOGY BIOSIMILARS MARKET SIZE, BY END-USER, 2017-2025 (USD MILLION)
TABLE 34. JAPAN ONCOLOGY BIOSIMILARS MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
TABLE 35. MALAYSIA ONCOLOGY BIOSIMILARS MARKET SIZE, BY END-USER, 2017-2025 (USD MILLION)
TABLE 36. MALAYSIA ONCOLOGY BIOSIMILARS MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
TABLE 37. PHILIPPINES ONCOLOGY BIOSIMILARS MARKET SIZE, BY END-USER, 2017-2025 (USD MILLION)
TABLE 38. PHILIPPINES ONCOLOGY BIOSIMILARS MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
TABLE 39. SOUTH KOREA ONCOLOGY BIOSIMILARS MARKET SIZE, BY END-USER, 2017-2025 (USD MILLION)
TABLE 40. SOUTH KOREA ONCOLOGY BIOSIMILARS MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
TABLE 41. THAILAND ONCOLOGY BIOSIMILARS MARKET SIZE, BY END-USER, 2017-2025 (USD MILLION)
TABLE 42. THAILAND ONCOLOGY BIOSIMILARS MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
TABLE 43. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY BIOSIMILARS MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 44. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY BIOSIMILARS MARKET SIZE, BY END-USER, 2017-2025 (USD MILLION)
TABLE 45. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY BIOSIMILARS MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
TABLE 46. FRANCE ONCOLOGY BIOSIMILARS MARKET SIZE, BY END-USER, 2017-2025 (USD MILLION)
TABLE 47. FRANCE ONCOLOGY BIOSIMILARS MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
TABLE 48. GERMANY ONCOLOGY BIOSIMILARS MARKET SIZE, BY END-USER, 2017-2025 (USD MILLION)
TABLE 49. GERMANY ONCOLOGY BIOSIMILARS MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
TABLE 50. ITALY ONCOLOGY BIOSIMILARS MARKET SIZE, BY END-USER, 2017-2025 (USD MILLION)
TABLE 51. ITALY ONCOLOGY BIOSIMILARS MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
TABLE 52. NETHERLANDS ONCOLOGY BIOSIMILARS MARKET SIZE, BY END-USER, 2017-2025 (USD MILLION)
TABLE 53. NETHERLANDS ONCOLOGY BIOSIMILARS MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
TABLE 54. QATAR ONCOLOGY BIOSIMILARS MARKET SIZE, BY END-USER, 2017-2025 (USD MILLION)
TABLE 55. QATAR ONCOLOGY BIOSIMILARS MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
TABLE 56. RUSSIA ONCOLOGY BIOSIMILARS MARKET SIZE, BY END-USER, 2017-2025 (USD MILLION)
TABLE 57. RUSSIA ONCOLOGY BIOSIMILARS MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
TABLE 58. SAUDI ARABIA ONCOLOGY BIOSIMILARS MARKET SIZE, BY END-USER, 2017-2025 (USD MILLION)
TABLE 59. SAUDI ARABIA ONCOLOGY BIOSIMILARS MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
TABLE 60. SOUTH AFRICA ONCOLOGY BIOSIMILARS MARKET SIZE, BY END-USER, 2017-2025 (USD MILLION)
TABLE 61. SOUTH AFRICA ONCOLOGY BIOSIMILARS MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
TABLE 62. SPAIN ONCOLOGY BIOSIMILARS MARKET SIZE, BY END-USER, 2017-2025 (USD MILLION)
TABLE 63. SPAIN ONCOLOGY BIOSIMILARS MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
TABLE 64. UNITED ARAB EMIRATES ONCOLOGY BIOSIMILARS MARKET SIZE, BY END-USER, 2017-2025 (USD MILLION)
TABLE 65. UNITED ARAB EMIRATES ONCOLOGY BIOSIMILARS MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
TABLE 66. UNITED KINGDOM ONCOLOGY BIOSIMILARS MARKET SIZE, BY END-USER, 2017-2025 (USD MILLION)
TABLE 67. UNITED KINGDOM ONCOLOGY BIOSIMILARS MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
TABLE 68. GLOBAL ONCOLOGY BIOSIMILARS MARKET: SCORES
TABLE 69. GLOBAL ONCOLOGY BIOSIMILARS MARKET: BUSINESS STRATEGY
TABLE 70. GLOBAL ONCOLOGY BIOSIMILARS MARKET: PRODUCT SATISFACTION
TABLE 71. GLOBAL ONCOLOGY BIOSIMILARS MARKET: RANKING
TABLE 72. GLOBAL ONCOLOGY BIOSIMILARS MARKET: MERGER & ACQUISITION
TABLE 73. GLOBAL ONCOLOGY BIOSIMILARS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 74. GLOBAL ONCOLOGY BIOSIMILARS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 75. GLOBAL ONCOLOGY BIOSIMILARS MARKET: INVESTMENT & FUNDING
TABLE 76. GLOBAL ONCOLOGY BIOSIMILARS MARKET: AWARD, RECOGNITION, & EXPANSION

Companies Mentioned

Amgen
Baxter
Biocon
Cipla
Dr Reddy’s Laboratories
F Hoffmann-la Roche
Hospira
Pfizer
Sandoz
Sanofi